Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Evaluations for Possible MS Often Turn up One of its Many Mimics

Publish date:: March 9, 2019

Key clinical point: Most patients referred to two MS centers for a possible diagnosis did not have MS.

Major finding: Of 95 patients referred for a question of MS diagnosis, 60% had clinical syndromes atypical for MS, 22% had normal neurologic exams.

Study details: Retrospective review of 95 patients referred to two MS centers for a possible diagnosis of MS.

Disclosures: The researchers had no relevant disclosures.

Citation:

Kaisey M et al. ACTRIMS Forum 2019, Abstract 90.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Multiple Sclerosis

Long-term safety and efficacy of teriflunomide for relapsing MS,

Newer DMTs are more effective than injectable DMTs in pediatric MS,

Neutrophil granulocyte markers may distinguish between demyelinating diseases,

Bacteria may be associated with risk of MS relapse,

Women with MS may have increased subclinical disease activity during pregnancy,